Cargando…
Remimazolam-based anesthesia with flumazenil allows faster emergence than propofol-based anesthesia in older patients undergoing spinal surgery: A randomized controlled trial
BACKGROUND: Remimazolam is a novel, ultrashort-acting benzodiazepine that can be antagonized by flumazenil. This study aimed to determine whether remimazolam-based anesthesia with flumazenil provides a more rapid emergence than propofol-based anesthesia in older patients undergoing spinal surgery. M...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659722/ https://www.ncbi.nlm.nih.gov/pubmed/37986333 http://dx.doi.org/10.1097/MD.0000000000036081 |
_version_ | 1785148372802338816 |
---|---|
author | Toyota, Yukari Kondo, Takashi Oshita, Kyoko Haraki, Toshiaki Narasaki, Soshi Kido, Kenshiro Kamiya, Satoshi Nakamura, Ryuji Saeki, Noboru Horikawa, Yousuke T. Tsutsumi, Yasuo M. |
author_facet | Toyota, Yukari Kondo, Takashi Oshita, Kyoko Haraki, Toshiaki Narasaki, Soshi Kido, Kenshiro Kamiya, Satoshi Nakamura, Ryuji Saeki, Noboru Horikawa, Yousuke T. Tsutsumi, Yasuo M. |
author_sort | Toyota, Yukari |
collection | PubMed |
description | BACKGROUND: Remimazolam is a novel, ultrashort-acting benzodiazepine that can be antagonized by flumazenil. This study aimed to determine whether remimazolam-based anesthesia with flumazenil provides a more rapid emergence than propofol-based anesthesia in older patients undergoing spinal surgery. METHODS: This was a prospective, single-blind, randomized controlled trial. Forty-four patients > 75 years old who had undergone spinal surgery were enrolled in this study. They were randomly assigned to the remimazolam or propofol group (1:1) using a computer randomization system stratified by age and body weight. For anesthesia induction and maintenance, remifentanil was administered at a defined dose in both groups, and remimazolam or propofol was adjusted to maintain the bispectral index or state entropy monitoring within 40–60. All anesthetics were discontinued simultaneously after the postoperative X-ray and 0.5 mg flumazenil was administered to the remimazolam group. The primary outcome was extubation time after discontinuing anesthesia, and the secondary outcomes were time to eye opening, obeying commands, and achieving a white fast-track score (WFTS) of 12. RESULTS: Thirty-nine patients were finally analyzed: remimazolam group (n = 20), propofol group (n = 19). There were no significant differences in intraoperative variables, such as operative time, anesthesia time, and patient background, between the 2 groups. Extubation times were significantly shorter in the remimazolam group than in the propofol group (4 vs 8 minutes, P < .001). The time to eye opening, obeying commands, and achieving a WFTS of 12 were significantly shorter in the remimazolam group (P < .001, for all comparisons). CONCLUSION: Remimazolam-based anesthesia with flumazenil resulted in a faster emergence than propofol-based anesthesia in older patients undergoing spinal surgery. |
format | Online Article Text |
id | pubmed-10659722 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-106597222023-11-17 Remimazolam-based anesthesia with flumazenil allows faster emergence than propofol-based anesthesia in older patients undergoing spinal surgery: A randomized controlled trial Toyota, Yukari Kondo, Takashi Oshita, Kyoko Haraki, Toshiaki Narasaki, Soshi Kido, Kenshiro Kamiya, Satoshi Nakamura, Ryuji Saeki, Noboru Horikawa, Yousuke T. Tsutsumi, Yasuo M. Medicine (Baltimore) 3300 BACKGROUND: Remimazolam is a novel, ultrashort-acting benzodiazepine that can be antagonized by flumazenil. This study aimed to determine whether remimazolam-based anesthesia with flumazenil provides a more rapid emergence than propofol-based anesthesia in older patients undergoing spinal surgery. METHODS: This was a prospective, single-blind, randomized controlled trial. Forty-four patients > 75 years old who had undergone spinal surgery were enrolled in this study. They were randomly assigned to the remimazolam or propofol group (1:1) using a computer randomization system stratified by age and body weight. For anesthesia induction and maintenance, remifentanil was administered at a defined dose in both groups, and remimazolam or propofol was adjusted to maintain the bispectral index or state entropy monitoring within 40–60. All anesthetics were discontinued simultaneously after the postoperative X-ray and 0.5 mg flumazenil was administered to the remimazolam group. The primary outcome was extubation time after discontinuing anesthesia, and the secondary outcomes were time to eye opening, obeying commands, and achieving a white fast-track score (WFTS) of 12. RESULTS: Thirty-nine patients were finally analyzed: remimazolam group (n = 20), propofol group (n = 19). There were no significant differences in intraoperative variables, such as operative time, anesthesia time, and patient background, between the 2 groups. Extubation times were significantly shorter in the remimazolam group than in the propofol group (4 vs 8 minutes, P < .001). The time to eye opening, obeying commands, and achieving a WFTS of 12 were significantly shorter in the remimazolam group (P < .001, for all comparisons). CONCLUSION: Remimazolam-based anesthesia with flumazenil resulted in a faster emergence than propofol-based anesthesia in older patients undergoing spinal surgery. Lippincott Williams & Wilkins 2023-11-17 /pmc/articles/PMC10659722/ /pubmed/37986333 http://dx.doi.org/10.1097/MD.0000000000036081 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | 3300 Toyota, Yukari Kondo, Takashi Oshita, Kyoko Haraki, Toshiaki Narasaki, Soshi Kido, Kenshiro Kamiya, Satoshi Nakamura, Ryuji Saeki, Noboru Horikawa, Yousuke T. Tsutsumi, Yasuo M. Remimazolam-based anesthesia with flumazenil allows faster emergence than propofol-based anesthesia in older patients undergoing spinal surgery: A randomized controlled trial |
title | Remimazolam-based anesthesia with flumazenil allows faster emergence than propofol-based anesthesia in older patients undergoing spinal surgery: A randomized controlled trial |
title_full | Remimazolam-based anesthesia with flumazenil allows faster emergence than propofol-based anesthesia in older patients undergoing spinal surgery: A randomized controlled trial |
title_fullStr | Remimazolam-based anesthesia with flumazenil allows faster emergence than propofol-based anesthesia in older patients undergoing spinal surgery: A randomized controlled trial |
title_full_unstemmed | Remimazolam-based anesthesia with flumazenil allows faster emergence than propofol-based anesthesia in older patients undergoing spinal surgery: A randomized controlled trial |
title_short | Remimazolam-based anesthesia with flumazenil allows faster emergence than propofol-based anesthesia in older patients undergoing spinal surgery: A randomized controlled trial |
title_sort | remimazolam-based anesthesia with flumazenil allows faster emergence than propofol-based anesthesia in older patients undergoing spinal surgery: a randomized controlled trial |
topic | 3300 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659722/ https://www.ncbi.nlm.nih.gov/pubmed/37986333 http://dx.doi.org/10.1097/MD.0000000000036081 |
work_keys_str_mv | AT toyotayukari remimazolambasedanesthesiawithflumazenilallowsfasteremergencethanpropofolbasedanesthesiainolderpatientsundergoingspinalsurgeryarandomizedcontrolledtrial AT kondotakashi remimazolambasedanesthesiawithflumazenilallowsfasteremergencethanpropofolbasedanesthesiainolderpatientsundergoingspinalsurgeryarandomizedcontrolledtrial AT oshitakyoko remimazolambasedanesthesiawithflumazenilallowsfasteremergencethanpropofolbasedanesthesiainolderpatientsundergoingspinalsurgeryarandomizedcontrolledtrial AT harakitoshiaki remimazolambasedanesthesiawithflumazenilallowsfasteremergencethanpropofolbasedanesthesiainolderpatientsundergoingspinalsurgeryarandomizedcontrolledtrial AT narasakisoshi remimazolambasedanesthesiawithflumazenilallowsfasteremergencethanpropofolbasedanesthesiainolderpatientsundergoingspinalsurgeryarandomizedcontrolledtrial AT kidokenshiro remimazolambasedanesthesiawithflumazenilallowsfasteremergencethanpropofolbasedanesthesiainolderpatientsundergoingspinalsurgeryarandomizedcontrolledtrial AT kamiyasatoshi remimazolambasedanesthesiawithflumazenilallowsfasteremergencethanpropofolbasedanesthesiainolderpatientsundergoingspinalsurgeryarandomizedcontrolledtrial AT nakamuraryuji remimazolambasedanesthesiawithflumazenilallowsfasteremergencethanpropofolbasedanesthesiainolderpatientsundergoingspinalsurgeryarandomizedcontrolledtrial AT saekinoboru remimazolambasedanesthesiawithflumazenilallowsfasteremergencethanpropofolbasedanesthesiainolderpatientsundergoingspinalsurgeryarandomizedcontrolledtrial AT horikawayousuket remimazolambasedanesthesiawithflumazenilallowsfasteremergencethanpropofolbasedanesthesiainolderpatientsundergoingspinalsurgeryarandomizedcontrolledtrial AT tsutsumiyasuom remimazolambasedanesthesiawithflumazenilallowsfasteremergencethanpropofolbasedanesthesiainolderpatientsundergoingspinalsurgeryarandomizedcontrolledtrial |